ChemMedChem
John Wiley and Sons Ltd · United Kingdom · Est. 1822
Aims & Scope✦ Inferred from recent articles
This journal focuses on the design, synthesis, and evaluation of novel chemical compounds with potential therapeutic applications. Research areas include the development of antibacterial agents, kinase inhibitors for cancer therapy, compounds targeting neurodegenerative diseases and cancer, DNA-binding ligands for anticancer drug development, modulators of the endocannabinoid system and kainate receptors, fluorescent probes for disease visualization, inhibitors of viral targets like influenza and SARS-CoV-2, and agents targeting epigenetic regulators. The journal also covers medicinal chemistry approaches to drug discovery, including structure-activity relationship studies, fragment-based drug discovery, and the use of computational and biophysical methods.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref